Trial intelligence / Profile preview

Intraovarian PRP injection for poor ovarian response during IVF

IRCT20141217020351N11Phase 4Completed

Sponsor
Tehran University of Medical Sciences
Start
Oct 2020
Countries
1
01

Overview

Phase 4, open-label trial of platelet-rich plasma in female infertility and poor ovarian response (POR) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Number of eggs grown and Anti-Mullerian hormone level. Started Oct 2020; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

female infertilitypoor ovarian response (POR)

Beyond the preview

Go deeper on IRCT20141217020351N11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141217020351N11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call